Background Due to technical limitations of commonly used tonometry devices, the effects of physical exercise on intraocular ...

Gland Pharma has received USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, intended to treat high eye ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company advancing innovative treatments targeting the ...

DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

Pykus Therapeutics reveals promising results for PYK-2101, a retinal sealant that enhances recovery and improves patient ...

Gland Pharma receives USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, a bioequivalent to Bausch and ...

Hyderabad: Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has announced that the ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

Verana Health’s newly launched Qdata Cataract offers a comprehensive dataset to improve outcomes, reduce complications and ...

Gland Pharma on Wednesday said it has received approval from the US health regulator for a generic medication to treat ...

The ophthalmic solution is used to decrease intraocular pressure in open-angle glaucoma or ocular hypertension patients.

The product is bioequivalent and therapeutically equivalent to the reference listing drug VYZULTA Opthalmic solution, 0.024% ...